Category: Breaking

Breaking News

Supreme Court Declines to Hear PhRMA’s Challenge to Arkansas’ Landmark 340B Contract Pharmacy Access Law

December 9, 2024 William Newton, Associate Editor/Senior Writer Views

The Supreme Court announced on Dec. 9 that it would not take up PhRMA's appeal challenging an Arkansas 340B law.

The U.S. Supreme Court earlier today declined to hear an influential drug industry trade group’s appeal challenging Arkansas’ first-in-the-nation 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Wall Street Journal Reports Sanofi Will Become Third Drugmaker to Push for Controversial 340B Rebate

November 22, 2024 William Newton, Associate Editor/Senior Writer Views

Sanofi reportedly plans to announce a 340B rebate plan for certain hospitals.

French pharmaceutical giant Sanofi reportedly plans to announce a 340B rebate model for hospitals today, making it the third drugmaker [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly Sues HHS, HRSA to Implement Expansive 340B Rebate for All Products and Covered Entity Types

November 15, 2024 William Newton, Associate Editor/Senior Writer Views

A California-based hospital sued HHS Jan. 15 alleging it "unlawfully" prevented it from accessing the 340B program for six months.

Eli Lilly on Thursday sued the federal government to implement a sweeping 340B rebate model that would apply to all [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate GOP Selects Thune, a 340B Champion, as Next Majority Leader Despite Pushback from Trump Allies

November 13, 2024 Shannon Young, Associate Editor/Senior Writer Views

Senate Republicans on Wednesday selected U.S. Sen. John Thune (R-S.D.) as their next majority leader.

One week after clinching control of the U.S. Senate, GOP senators elected U.S. Sen. John Thune (R-S.D.), the chamber’s second-ranking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J Sues HRSA for Blocking Controversial 340B Rebate Model

November 12, 2024 William Newton, Associate Editor/Senior Writer Views

J&J is suing the federal government to implement the drugmaker's controversial 340B rebate proposal.

Johnson & Johnson (J&J) earlier today sued the federal government to establish a 340B rebate model, marking the latest escalation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J Abandons 340B Rebate Due to HRSA’s Enforcement Threats But Defends Model in Letter to Agency

September 30, 2024 William Newton, Associate Editor/Senior Writer Views

J&J announced it will "forgo implementation" of its 340B rebate proposal due to enforcement threats from HRSA.

Johnson & Johnson (J&J) notified the Health Resources and Services Administration (HRSA) this morning that it will drop its 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

188 Bipartisan House Members Urge HHS Action Against J&J’s ‘Unlawful’ 340B Rebate Proposal

September 27, 2024 William Newton, Associate Editor/Senior Writer Views

A bipartisan group of 188 House members sent HHS a letter urging action against J&J's 340B rebate proposal.

A bipartisan group of 188 House lawmakers urged the federal government Friday to “use every enforcement tool” at its disposal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA to J&J: End 340B Rebate by Monday or Lose Access to Key Government Health Insurance Markets

September 27, 2024 William Newton, Associate Editor/Senior Writer Views

HHS and HRSA sent J&J a Sept. 27 letter that again threatened tough enforcement action against the drugmaker's 340B rebate proposal.

The federal agency overseeing the 340B program has doubled down on its threat to terminate Johnson & Johnson’s (J&J’s) access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senator Cassidy Extends 340B Inquiry to Two Major Pharmaceutical Manufacturers

September 23, 2024 William Newton, Associate Editor/Senior Writer Views

Sen. Bill Cassidy (R-La.) has extended an ongoing 340B probe to two major drug manufacturers.

An influential Republican senator this morning requested detailed information from Eli Lilly and Amgen on their 340B programs, including the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HHS to J&J: End 340B Rebate Proposal Immediately or ‘Face Potential Consequences’—Including Termination from Federal Health Insurance Programs

September 17, 2024 William Newton, Associate Editor/Senior Writer Views

HHS sent J&J a Sept. 17 letter demanding the drugmaker "immediately" cease its plan to implement a 340B rebate model.

The federal agency that oversees the 340B program today formally warned Johnson & Johnson (J&J) that it must “cease implementation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live